181 related articles for article (PubMed ID: 29076126)
21. A phase 2 biomarker-driven study of ruxolitinib demonstrates effectiveness of JAK/STAT targeting in T-cell lymphomas.
Moskowitz AJ; Ghione P; Jacobsen E; Ruan J; Schatz JH; Noor S; Myskowski P; Vardhana S; Ganesan N; Hancock H; Davey T; Perez L; Ryu S; Santarosa A; Dowd J; Obadi O; Pomerantz L; Yi N; Sohail S; Galasso N; Neuman R; Liotta B; Blouin W; Baik J; Geyer MB; Noy A; Straus D; Kumar P; Dogan A; Hollmann T; Drill E; Rademaker J; Schoder H; Inghirami G; Weinstock DM; Horwitz SM
Blood; 2021 Dec; 138(26):2828-2837. PubMed ID: 34653242
[TBL] [Abstract][Full Text] [Related]
22. Biology and significance of the JAK/STAT signalling pathways.
Kiu H; Nicholson SE
Growth Factors; 2012 Apr; 30(2):88-106. PubMed ID: 22339650
[TBL] [Abstract][Full Text] [Related]
23. JAK/STAT signaling in hematological malignancies.
Vainchenker W; Constantinescu SN
Oncogene; 2013 May; 32(21):2601-13. PubMed ID: 22869151
[TBL] [Abstract][Full Text] [Related]
24. Inteferons pen the JAK-STAT pathway.
Schindler C; Plumlee C
Semin Cell Dev Biol; 2008 Aug; 19(4):311-8. PubMed ID: 18765289
[TBL] [Abstract][Full Text] [Related]
25. The JAK/STAT pathway regulates proximo-distal patterning in Drosophila.
Ayala-Camargo A; Ekas LA; Flaherty MS; Baeg GH; Bach EA
Dev Dyn; 2007 Oct; 236(10):2721-30. PubMed ID: 17626283
[TBL] [Abstract][Full Text] [Related]
26. IL7R overexpression in adult acute lymphoblastic leukemia is associated to JAK/STAT pathway mutations and identifies patients who could benefit from targeted therapies.
Gianfelici V; Messina M; Paoloni F; Peragine N; Lauretti A; Fedullo AL; Di Giacomo F; Vignetti M; Vitale A; Guarini A; Chiaretti S; Foà R
Leuk Lymphoma; 2019 Mar; 60(3):829-832. PubMed ID: 30188230
[No Abstract] [Full Text] [Related]
27. Gα73B is a downstream effector of JAK/STAT signalling and a regulator of Rho1 in Drosophila haematopoiesis.
Bausek N; Zeidler MP
J Cell Sci; 2014 Jan; 127(Pt 1):101-10. PubMed ID: 24163435
[TBL] [Abstract][Full Text] [Related]
28. Disclosing JAK/STAT links to cell adhesion and cell polarity.
Hombría JC; Sotillos S
Semin Cell Dev Biol; 2008 Aug; 19(4):370-8. PubMed ID: 18590829
[TBL] [Abstract][Full Text] [Related]
29. Comparative analysis of the JAK/STAT signaling through erythropoietin receptor and thrombopoietin receptor using a systems approach.
Won HH; Park I; Lee E; Kim JW; Lee D
BMC Bioinformatics; 2009 Jan; 10 Suppl 1(Suppl 1):S53. PubMed ID: 19208156
[TBL] [Abstract][Full Text] [Related]
30. JAK and STAT members in channel catfish: Identification, phylogenetic analysis and expression profiling after Edwardsiella ictaluri infection.
Jin Y; Zhou T; Li N; Liu S; Xu X; Pan Y; Tan S; Shi H; Yang Y; Yuan Z; Wang W; Luo J; Gao D; Dunham R; Liu Z
Dev Comp Immunol; 2018 Apr; 81():334-341. PubMed ID: 29274790
[TBL] [Abstract][Full Text] [Related]
31. JAK/STAT signaling regulates the Harmonia axyridis leg regeneration by coordinating cell proliferation.
Zhou H; Wang W; Yan S; Zhang J; Wang D; Shen J
Dev Biol; 2022 Mar; 483():98-106. PubMed ID: 34999052
[TBL] [Abstract][Full Text] [Related]
32. Challenges and implications of genomics for T-cell lymphomas.
Jacobsen ED; Weinstock DM
Hematology Am Soc Hematol Educ Program; 2018 Nov; 2018(1):63-68. PubMed ID: 30504292
[TBL] [Abstract][Full Text] [Related]
33. Clinical features and prognosis of pediatric acute lymphocytic leukemia with JAK-STAT pathway genetic abnormalities: a case series.
Hu M; Liu R; Li J; Zhang L; Cao J; Yue M; Zhong D; Tang R
Ann Hematol; 2023 Sep; 102(9):2445-2457. PubMed ID: 37209119
[TBL] [Abstract][Full Text] [Related]
34. Emerging roles of JAK-STAT signaling pathways in adipocytes.
Richard AJ; Stephens JM
Trends Endocrinol Metab; 2011 Aug; 22(8):325-32. PubMed ID: 21561789
[TBL] [Abstract][Full Text] [Related]
35. Targeting the JAK/STAT Pathway in T Cell Lymphoproliferative Disorders.
Shouse G; Nikolaenko L
Curr Hematol Malig Rep; 2019 Dec; 14(6):570-576. PubMed ID: 31741284
[TBL] [Abstract][Full Text] [Related]
36. Methylome analysis reveals Jak-STAT pathway deregulation in putative breast cancer stem cells.
Hernandez-Vargas H; Ouzounova M; Le Calvez-Kelm F; Lambert MP; McKay-Chopin S; Tavtigian SV; Puisieux A; Matar C; Herceg Z
Epigenetics; 2011 Apr; 6(4):428-39. PubMed ID: 21266853
[TBL] [Abstract][Full Text] [Related]
37. LncRNA-135528 inhibits tumor progression by up-regulating CXCL10 through the JAK/STAT pathway.
Wang P; Peng X; Zhang J; Wang Z; Meng J; Cen B; Ji A; He S
Apoptosis; 2018 Dec; 23(11-12):651-666. PubMed ID: 30232656
[TBL] [Abstract][Full Text] [Related]
38. [JAK/STAT: from inflammation to memory].
Nicolas CS; Csaba Z; Fafouri A; Javalet C; Gressens P; Dournaud P; Peineau S
Med Sci (Paris); 2012 May; 28(5):456-8. PubMed ID: 22642993
[No Abstract] [Full Text] [Related]
39. The JAK-STAT pathway: impact on human disease and therapeutic intervention.
O'Shea JJ; Schwartz DM; Villarino AV; Gadina M; McInnes IB; Laurence A
Annu Rev Med; 2015; 66():311-28. PubMed ID: 25587654
[TBL] [Abstract][Full Text] [Related]
40. Canonical JAK-STAT signaling is pivotal for long-term depression at adult hippocampal temporoammonic-CA1 synapses.
McGregor G; Irving AJ; Harvey J
FASEB J; 2017 Aug; 31(8):3449-3466. PubMed ID: 28461339
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
